EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A CNS-Directed, AAV9 Gene Therapy Restores Expression and Biochemical Function of Guanidinoacetate Methyltransferase in Models of GAMT Deficiency

Robyn Binsfeld iD, Troy Webster, Ilona Tkachyova, Michael Tropak, Melissa Mitchell iD, Tesla Peretti iD, Andreas Schulze iD, Jagdeep S Walia iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27021035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Robyn Binsfeld und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuroscience Studies, Queen's University, Kingston, ON K7L 3N6, Canada. Hauptthemen laut MEDLINE: Guanidinoacetate N-Methyltransferase, Genetic Therapy, Dependovirus, Movement Disorders. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Initiation Grant from Queen’s University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guanidinoacetate methyltransferase (GAMT) is an essential enzyme in the biosynthesis of creatine, an important molecule in energy recycling. GAMT loss of function leads to GAMT deficiency (GAMT-D), an autosomal recessive disorder resulting in low creatine levels and the accumulation of a toxic intermediate, guanidinoacetate (GAA). GAMT-D patients present with intellectual disability and epilepsy, emphasizing the detrimental consequences of disturbed creatine metabolisms in the central nervous system (CNS). Current treatments are not curative and may not restore creatine metabolism in the brain. Here, we present a proof-of concept study testing the first CNS-directed, Adeno-associated virus serotype 9 (AAV9)-based gene therapy for the treatment of GAMT-D. the delivery of GAMT construct to cellular models of GAMT-D effectively restored protein and mRNA expression of GAMT while increasing intracellular creatine content and decreasing GAA accumulation. In murine models of GAMT-D, treatment with scAAV9.hGAMT, delivered intrathecally, resulted in increased creatine content as well as significant decreases in GAA accumulation in the CNS and peripheral organs. Overall, we found that scAAV9.hGAMT represents a promising gene therapy for treating GAMT-D, warranting further investigation in animal models to determine an appropriate therapeutic window for both efficacy and safety that allows for translation into human patients in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guanidinoacetate N-MethyltransferaseGenetic TherapyDependovirusMovement DisordersLanguage Development DisordersCentral Nervous SystemAnimalsMiceHumansCreatineDisease Models, AnimalGene Therapy AgentsGenetic VectorsMaleBrain

Stichwörter der Autor:innen

AAV9GAMT deficiencycreatine deficiencygene therapyintrathecalscAAV9.hGAMT therapy

Substanzen

Guanidinoacetate N-MethyltransferaseCreatine

Autor:innen und Institutionen

  • Centre for Neuroscience Studies, Queen's University, Kingston, ON K7L 3N6, Canada.
  • The Hospital for Sick Children, Toronto, ON M5G 1E8, Canada.
  • Peter Gilgan Center for Research and Learning, Toronto, ON M5G 0A4, Canada.
  • Department of Pediatrics, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Departments of Pediatrics and Biochemistry, University of Toronto, Toronto, ON M5S 1A1, Canada.

ORCID-Profile: Robyn Binsfeld, Melissa Mitchell, Tesla Peretti, Andreas Schulze, Jagdeep S Walia

Förderung

  • Research Initiation Grant from Queen’s University

Zitieren

APA

Binsfeld, R., Webster, T., Tkachyova, I., Tropak, M., Mitchell, M., Peretti, T., Schulze, A., & Walia, J. S. (2026). A CNS-Directed, AAV9 Gene Therapy Restores Expression and Biochemical Function of Guanidinoacetate Methyltransferase in Models of GAMT Deficiency. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27021035

Vancouver

Binsfeld R, Webster T, Tkachyova I, Tropak M, Mitchell M, Peretti T, et al. A CNS-Directed, AAV9 Gene Therapy Restores Expression and Biochemical Function of Guanidinoacetate Methyltransferase in Models of GAMT Deficiency. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27021035

BibTeX
@article{Binsfeld2026,
  author = {Binsfeld, Robyn and Webster, Troy and Tkachyova, Ilona and Tropak, Michael and Mitchell, Melissa and Peretti, Tesla and Schulze, Andreas and Walia, Jagdeep S},
  title = {A CNS-Directed, AAV9 Gene Therapy Restores Expression and Biochemical Function of Guanidinoacetate Methyltransferase in Models of GAMT Deficiency},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27021035}
}
Kostenlos starten →